Moderna has collaborated with CDMO Recipharm to support formulation of its COVID-19 vaccine, mRNA-1273. The vaccine was approved for emergency use in the US in December, and today the European Medicines Agency has recommended the vaccine for authorization. Recipharm is set to join Moderna’s network of contract development and manufacturing organizations (CDMOs) to support mRNA-1273, a cell-free COVID-19 vaccine which, based on evidence from clinical trials, is 94.1% effective at protecting people from SARS-CoV-2. The terms of the agreement have…
Wednesday, January 6, 2021 Daily Archives
Up on the downstream: Sartorius to buy Novasep’s chromatography division
Sartorius Stedim Biotech says it continues to take on the challenges in efficient downstream processing through the proposed addition of Novasep’s chromatography equipment business. The deal, set to go through in the next few months, will see Sartorius bolster its downstream offering within its Stedim Biotech bioprocessing division. Financial terms have not been disclosed for now, and the acquisition is dependent on antitrust approvals. “The unit to acquire comprises resin-based batch and intensified chromatography systems, and primarily focuses on high-pressure,…